Entries by groupH

Seasons Greetings 2020

Much has been said about the extraordinary year that we have all experienced since March. Despite all the difficulties many have experienced, hardship in our industry has been relatively minimal but sadly, suffering due to Covid-19, is ongoing in particular in Low to Middle Income Countries with weak Healthcare systems. As all communication has shifted […]

The Human Side of Forecasting – Avoiding pitfalls facing Business Review Committees

The role of the forecaster extends beyond the modelling and the numbers, and all too often you may find yourself presenting cross-departmentally to your organisational equivalent of a Business Review Committee, for example, or to another organisation. This may not be an ad-hoc event, but many months of bringing all the pieces together may lead […]

Post CoVID-19: a new normal for carbon emissions in Pharma Market Research?

During the CoVID lockdown, have you thought to yourself: wow, our industry’s carbon emissions must have gone down dramatically? Would you be curious to find out by just how much? Erik Holzinger will be chairing a webinar by Bors Hulesch, of Brains & Cheek, looking at this very issue. Tuesday 6th October – 15.00 – […]

A message from the directors – Covid 19 / groupH operating normally

Dear clients, friends and colleagues, No doubt, everyone has been impacted by Covid-19 in more than one way and every week we learn more about the clinical impact of the virus and its impact on communities, the economy and livelihoods. We anticipate that the situation of social distancing measures is here to stay until at […]

Seasons Greetings 2019

This year we looked to use the simplicity of a Japanese ensō drawing to describe what we do on a daily basis. London-based artist, Yamuna Devi, created a circle from an improvised single brush stroke and placed different stages of our work anti-clockwise on this circle, describing our stages of work, including: market research, analysis, using different […]

groupH Christmas Celebration 2019

As 2019 draws to a close the groupH team came together to reconnect and reflect on another busy year.  It made for a truly special occasion to see colleagues from as far afield as San Francisco, Spain, Germany and Scotland in one place.  Our venue was the Cromwell Room in the historic and beautiful St […]

UPDATE: our take on CMS’s latest memo on CAR-T reimbursement

Earlier in the year, we reviewed the reimbursement challenges that CAR-T therapies are experiencing in the US, assessed some of the proposed solutions, and outlined Payers’ expectations from next-generation CAR-T therapies. Click here to see the original analysis. CMS published a memo providing an update to CAR-T reimbursement in early August that included a number […]

Forecasting and Data Analytics Round Table Discussions – EphMRA 2019

Following the positive feedback from the inaugural Forecasting Roundtable Discussion from 2018, Erik Holzinger/groupH facilitated another 1-hour discussion together with Pascal Olier/Pierre Fabre on the topic of Forecasting and Data Analytics. There was a large group of attendees consisting of some very experienced individuals from both the pharma company and agency side, with regard to […]